Private Capital Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $135K | Buy |
3,634
+368
| +11% | +$13.7K | 0.1% | 199 |
|
|
2022
Q1 | $145K | Buy |
3,266
+82
| +3% | +$3.64K | 0.03% | 298 |
|
|
2021
Q4 | $135K | Buy |
3,184
+248
| +8% | +$10.5K | 0.03% | 329 |
|
|
2021
Q3 | $127K | Buy |
2,936
+963
| +49% | +$41.7K | 0.03% | 339 |
|
|
2021
Q2 | $84K | Buy |
1,973
+40
| +2% | +$1.7K | 0.02% | 476 |
|
|
2021
Q1 | $75K | Sell |
1,933
-770
| -28% | -$29.9K | 0.02% | 484 |
|
|
2020
Q4 | $97K | Buy |
2,703
+544
| +25% | +$19.5K | 0.02% | 510 |
|
|
2020
Q3 | $82K | Buy |
2,159
+684
| +46% | +$26K | 0.02% | 511 |
|
|
2020
Q2 | $52K | Buy |
1,475
+283
| +24% | +$9.98K | 0.01% | 687 |
|
|
2020
Q1 | $39K | Sell |
1,192
-716
| -38% | -$23.4K | 0.01% | 746 |
|
|
2019
Q4 | $86K | Buy |
1,908
+1,351
| +243% | +$60.9K | 0.02% | 492 |
|
|
2019
Q3 | $23K | Buy |
557
+30
| +6% | +$1.24K | ﹤0.01% | 1121 |
|
|
2019
Q2 | $17K | Buy |
527
+64
| +14% | +$2.07K | ﹤0.01% | 1149 |
|
|
2019
Q1 | $18K | Sell |
463
-846
| -65% | -$32.9K | ﹤0.01% | 1251 |
|
|
2018
Q4 | $46K | Buy |
1,309
+937
| +252% | +$32.9K | 0.01% | 701 |
|
|
2018
Q3 | $14K | Sell |
372
-155
| -29% | -$5.83K | ﹤0.01% | 1301 |
|
|
2018
Q2 | $17K | Hold |
527
| – | – | ﹤0.01% | 1181 |
|
|
2018
Q1 | $14K | Sell |
527
-31
| -6% | -$824 | ﹤0.01% | 1219 |
|
|
2017
Q4 | $14 | Buy |
+558
| New | +$14 | ﹤0.01% | 1219 |
|